Philmans Pharm, Cenedella.de, The German Patient Roundtable

Est. 1977

Isodiol sets up operations in Mexico to begin shipping cannabis products and are now working on a manufacturing permit to produce medical marijuana with less than 1% THC

VANCOUVER — Isodiol International Inc., a developer of cannabis products for the pharmaceutical and consumer markets, has established operations in Mexico.

Mexico has officially legalized medical marijuana with less than 1% THC.

The Vancouver-based company has invested in infrastructure to expand its distribution into the market.

“Through our online sales platform, we will immediately be able to commence distribution and build a footprint within Mexico,” said Marcos Agramont, the company’s CEO and director. “We will also continue to work through the approval process with Comision Federal para la Proteccion contra Riesgos Sanitarios for our manufacturing permit which will allow us to produce in Mexico.”

Author: Cenedella.de

Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA +49.0.151.720.17652 GERMANY Skype: philip.j.cenedella eMail: phil@cenedella.de LinkedIN: https://www.linkedin.com/in/cenedellade/

Comments are closed.